Company / Inventory
TG Therapeutics, Inc. Inventory History
FY2022-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Inventory
$125.6M
FY2025
5-year range
$0 / $125.6M
FY2022-FY2025
Trend
+13.7%
vs FY2024
Sector context
#40 of 105
Health Care
What the data says
At $126M, TG Therapeutics, Inc.'s inventory ranks #40 of 105 in the Health Care sector. Inventory has increased for 3 consecutive years, from $0 in FY2022 to $126M in FY2025.
Based on SEC 10-K filings.
$126M in FY2025.
Improved from $40M to $126M over the past 2 years.
Health Care sector context is included.
Inventory over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Sector benchmark
#40 of 105 in Health CareTop 38% of 105This company $125.6M Sector average $885.3M
▼
-85.8% below sector average
Key checks
Key Insights
- In FY2025, inventory increased 13.7% year-over-year.
- Ranks #40 out of 105 companies in the Health Care sector.
Company context
Key Data Points
- Altman Z-Score 1.05 (distress zone, below 1.8 threshold)
- Low earnings quality (accrual-heavy earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | InventoryValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $125.6M | +13.7% |
| FY2024 | $110.5M | +177.4% |
| FY2023 | $39.8M | - |
| FY2022 | $0 | - |
| FY2021 | - | - |
| FY2020 | - | - |
| FY2019 | - | - |
| FY2018 | - | - |
| FY2017 | - | - |
| FY2016 | - | - |
As of FY2025 · SEC 10-K · Updated Jun 30, 2026